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Abstract
Background: Evaluation of integrated care programmes for individuals with multi-morbidity requires a broader
evaluation framework and a broader definition of added value than is common in cost-utility analysis. This is
possible through the use of Multi-Criteria Decision Analysis (MCDA).
Methods and results: This paper presents the seven steps of an MCDA to evaluate 17 different integrated care
programmes for individuals with multi-morbidity in 8 European countries participating in the 4-year, EU-funded
SELFIE project. In step one, qualitative research was undertaken to better understand the decision-context of these
programmes. The programmes faced decisions related to their sustainability in terms of reimbursement,
continuation, extension, and/or wider implementation. In step two, a uniform set of decision criteria was defined in
terms of outcomes measured across the 17 programmes: physical functioning, psychological well-being, social
relationships and participation, enjoyment of life, resilience, person-centeredness, continuity of care, and total health
and social care costs. These were supplemented by programme-type specific outcomes. Step three presents the
quasi-experimental studies designed to measure the performance of the programmes on the decision criteria. Step
four gives details of the methods (Discrete Choice Experiment, Swing Weighting) to determine the relative
importance of the decision criteria among five stakeholder groups per country. An example in step five illustrates
the value-based method of MCDA by which the performance of the programmes on each decision criterion is
combined with the weight of the respective criterion to derive an overall value score. Step six describes how we
deal with uncertainty and introduces the Conditional Multi-Attribute Acceptability Curve. Step seven addresses the
interpretation of results in stakeholder workshops.
Discussion: By discussing our solutions to the challenges involved in creating a uniform MCDA approach for the
evaluation of different programmes, this paper provides guidance to future evaluations and stimulates debate on
how to evaluate integrated care for multi-morbidity.
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Background
With increasing life expectancy, the prevalence of
multi-morbidity and the individual and socio-economic
burden thereof is on the rise; this trend is seen world-
wide [1–3]. Multi-morbidity is commonly defined as the
co-occurrence of two or more chronic health conditions
within one individual [4]. Conditions can co-exist for a
number of reasons: they may share a common risk factor,
be part of the same underlying disease-continuum, one
disease may cause or increase the risk of the other or their
co-existence may be random chance. Compared to people
with single conditions, people with multi-morbidity have a
lower life expectancy [5], a worse quality of life [6], higher
healthcare utilization [7], and are more likely to be absent
from work [8] and leave the workforce prematurely [9].
Multi-morbidity disproportionally affects people with
lower socio-economic status; a Scottish study showed
that the onset of multi-morbidity occurred 10–15 years
earlier in people living in the most as compared to
the least deprived areas [10]. Furthermore, people
with multi-morbidity experience a greater burden of
disease caused by the fragmentation in or duplication
of services provided by multiple professionals working in
different sectors mostly following single-disease guidelines
[11, 12]. This may lead to conflicting treatment goals,
unforeseen treatment interactions and overly demanding
appeals on an individual’s self-management capability,
which jeopardises compliance.
The provision of integrated care is increasingly seen as
a means for addressing the complex needs of people
with multi-morbidity. Recently, the World Health
Organisation (WHO) has reinforced the importance of
integration of care in its worldwide call for
people-centred and integrated health services [13].
Various innovative programmes have been established
internationally to provide integrated care to individuals
with multi-morbidity [14–19]. Although attention for
multi-morbidity is increasing, to date there is still too lit-
tle research in this area [20], as a result of which the evi-
dence of the effectiveness and cost-effectiveness of such
programmes is relatively limited. This can be explained
by the disease-specific focus of most research, the adop-
tion of inadequate methodology to evaluate these com-
plex interventions, the challenges associated with data
collection and linkage, the inconsistent selection of out-
come measures and the lack of multi-morbidity-specific
outcome measures.
One of the aims of SELFIE, a large four-year European
Horizon2020-funded project that started in September
2015 (See Table 1), is to strengthen the evidence-base of
integrated care programmes for individuals with
multi-morbidity by using a comprehensive evaluation ap-
proach called Multi-Criteria Decision Analysis (MCDA)
[21, 22]. In SELFIE, eight countries, i.e., Austria, Croatia,
Germany, Hungary, the Netherlands (coordinator),
Norway, Spain, and the United Kingdom, are performing
MCDAs of 17 promising integrated care programmes for
multi-morbidity. The aim of this paper is to describe the
methodological details of the MCDA approach applied in
SELFIE by explaining the empirical study designs of the
programmes, the development of a uniform set of out-
come measures used in the MCDA evaluations, the
weight-elicitation methods to determine the importance
of the outcomes for the MCDA, and the uncertainty
analysis. This paper can provide inspiration and guidance
to future evaluations of integrated care programmes for
multi-morbidity and stimulate international debate on
how to comprehensively evaluate such programmes.
Methods and results
In this section we describe the selection of the integrated
care programmes, the general MCDA evaluation frame-
work and the implementation of the seven steps of
MCDA in the SELFIE project. The challenges involved
in this implementation and the choices we made to
overcome them are addressed in the discussion section.
Programme selection
To identify promising candidate programmes, each
country applied a search strategy using the findings from
an international scoping review that was also conducted
in the SELFIE project [19], national publications on
previous and on-going programmes and projects, and
consultation of national experts and networks. The final
selection of two to three programmes per country was
guided by a combination of scientific and pragmatic cri-
teria. The primary scientific criteria focused on the care
Table 1 About the SELFIE project
SELFIE (Sustainable intEgrated chronic care modeLs for multi-morbidity:
delivery, FInancing, and performancE) is a Horizon2020 funded EU
project that aims to contribute to the improvement of person-centred
care for persons with multi-morbidity by proposing evidence-based,
economically sustainable, integrated care programmes that stimulate
cooperation across health and social care and are supported by
appropriate financing and payment schemes.
More specifically, SELFIE aims to:
• Develop a taxonomy of promising integrated care programmes for
persons with multi-morbidity
• Provide evidence-based advice on matching financing/payment
schemes with adequate incentives to implement integrated care
• Provide empirical evidence of the impact of promising integrated care
on a wide range of outcomes using Multi-Criteria Decision Analysis
• Develop implementation and change strategies tailored to different
care settings and contexts in Europe, especially Central and Eastern
Europe
The SELFIE consortium includes eight organisations in the following
countries: the Netherlands (coordinator), Austria, Croatia, Germany,
Hungary, Norway, Spain, and the UK. https://www.selfie2020.eu [Grant
Agreement No 634288]
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process itself, requiring that the programmes addressed
multi-morbidity and met our operational definition of
integrated care. Multi-morbidity was defined as at least
two chronic conditions, physical or mental, occurring in
one person at the same time, where one is not just a
known complication of the other. Integrated care was
defined as the structured efforts to provide coordinated,
pro-active, person-centred, multidisciplinary care by two
or more communicating and collaborating care pro-
viders that may work at the same organisation or differ-
ent organisations, either within the healthcare or across
the health, social, or community care sector (including
informal care). We also gave priority to innovative pro-
grammes, i.e., bottom-up programmes with a clear goal
and programmes in which individuals and informal care-
givers had an active role, in which health- and social
care were collaborating, and that focussed on continuity
of care. Pragmatic selection criteria pertained to the
availability or collectability of outcomes data, an
on-going status of the programme for at least another
two years, the transferability to other care settings, and
the willingness to collaborate with the SELFIE project.
Moreover, we aimed to have a variation across
programmes with respect to their aims, target group,
scope (e.g., small-scale case finding, screening, regional
approaches, population health management), and focus
(e.g., prevention, collaboration between health- and
social care, palliative care, transfer care). The 17
programmes that were selected were grouped into four
categories: 1) population health management pro-
grammes (n = 6), 2) frail elderly programmes (n = 5), 3)
programmes for individuals at the end-of-life and oncol-
ogy patients (n = 3), and 4) programmes for vulnerable
individuals who face problems in multiple life domains,
like health, housing, and financial problems (n = 3). Fig. 1
shows where the programmes are situated. They are
further described in the section Measuring performance.
Evaluation framework
The reason to opt for MCDA as an evaluation method
stems from 1) the increased complexity of integrated
care programmes when they target individuals with mul-
tiple morbidities [23] and 2) the need to adopt a more
holistic, person-centred understanding of ‘value’ when
evaluating the added benefit of these programmes.
Regarding the first reason, integrated care programmes
are considered to be complex, even if they focus on a
single disease, because they commonly consist of a
package of interacting interventions that intervene at
different levels, i.e., they target individuals, providers,
organisations, and/or sectors [23]. This is reinforced
when the target population includes individuals with
multi-morbidity. What adds to the complexity is that the
programmes are tailored to the context in which they
are implemented, and they interact with this context.
During the dynamic implementation process, the pro-
grammes are continuously improved as more experience
is gained. Furthermore, these programmes have a variety
of intended outcomes at different levels, especially in
multi-morbidity, and their effectiveness is impacted by
the behaviour of those delivering and receiving the inter-
ventions. Regarding the second reason, we adopt a more
holistic, person-centred understanding of ‘value’ because
the standard cost-utility analysis in which a cost per QALY
is calculated may be insufficient to capture the whole
spectrum of relevant outcomes. Integrated care pro-
grammes, especially for individuals with multi-morbidity,
do not only aim to improve health but also well-being,
experience of care and efficiency. Sometimes the goal is
just to align the services better and organise sufficient
support to enable people to remain in control of their life.
As a consequence, we seek to adopt an evaluation frame-
work that is broad enough to incorporate a wide range of
different outcomes, called ‘criteria’ in MCDA-terminology,
to capture different components of the added value of
these programmes [24, 25].
In SELFIE, we are using a multi-attribute value-based
method of MCDA, which applies a weighting to the
various outcomes of an integrated care programme and
its comparator, from one or more perspectives, to calcu-
late an overall value score [26]. In this type of MCDA,
the performance of each integrated care programme and
its comparator on all criteria are determined separately
from the importance, or weights, of these criteria. For
both the programme and the comparator, the weighted
performance on each criterion is aggregated into an
overall value score, which is then compared between the
two. It was decided upfront that the MCDA method and
the weights should be re-usable in the future. To facili-
tate this, we plan to create an online tool with the
criteria weights from different perspectives (i.e., different
groups of stakeholders). Others can use the tool to
evaluate their own integrated care programmes in the
future.
Seven steps are commonly undertaken in an MCDA:
1) establish the decision-context, 2) identify and struc-
ture criteria, 3) determine the performance on criteria,
4) determine the weights of the criteria, 5) create an
overall value score, 6) perform sensitivity analyses, 7)
interpret results [27]. Below we describe how we have
applied these steps in SELFIE.
Decision context (step 1)
To better understand the context of the selected
programmes, we conducted qualitative research on each,
including document analyses and interviews with
programme-initiators, managers, representatives of payer
organisations, care providers (physicians, nurses, social
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care staff ), participants, and informal caregivers. This
resulted in 17 ‘thick description’ reports (accessible via
https://www.selfie2020.eu/). The thick descriptions were
structured according to the components of a conceptual
framework for integrated care for multi-morbidity that
was developed at the beginning of the SELFIE project
[28]. The individuals with multi-morbidity in their envir-
onment with their resources are the heart of the frame-
work that is surrounded by the micro, meso, and macro
layers of six components: 1) service delivery, 2) leader-
ship and governance, 3) workforce, 4) financing, 5) tech-
nologies and medical products, and 6) information and
research. Within these components, elements of
integrated care that have previously been reported to
contribute to its effectiveness are identified and
described in the framework. In the thick descriptions, a
formal description of the ‘hard facts’ in each component
is given, as well as a description that goes one layer
deeper and addresses the ‘soft facts’ that lay beneath the
surface. The hard facts include for example the formal
roles of the professionals involved, services provided,
organisational structure, legal status, ICT support, and
purchasing and payment contracts. The soft facts
include for example the culture of the organisation, the
extent to which there is a common vision, social rela-
tionships between staff members, management support,
and power issues. The thick descriptions also systematic-
ally describe the barriers to the implementation of the
programmes and strategies applied to overcome them.
Furthermore, the thick descriptions reviewed existing
evaluations of the programmes, most of which were meth-
odologically weak. To enhance our understanding of the
context in which the integrated care programmes are op-
erating, the thick descriptions start with a macro-level de-
scription of the health and social care systems and policies
in the country or region of interest.
The thick descriptions revealed that the decision-context
that these programmes face is related to long-term
sustainability in terms of reimbursement, continu-
ation, extension, and/or wider implementation in their
own region or country. Hence, the aim of the MCDA
is to inform these decisions by comparing each of the
17 programmes to usual care.
An important part of understanding the decision
context is identifying the stakeholders relevant to the
decision-making process, whose value judgements will
be included in the MCDA. The stakeholders consid-
ered relevant to inform the decision making
surrounding integrated care for multi-morbidity are
representatives of five groups (the 5P’s): Patients,
Partners and other informal caregivers, Professionals,
Payers, and Policy makers.
Fig. 1 Geographic overview of selected 17 programmes
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Criteria (step 2)
The second step in an MCDA, is to identify and
structure the decision criteria, which are the measures
of performance of the programmes that are considered
relevant to inform decision making. In SELFIE these are
defined in terms of outcomes. We created a long-list of
potentially relevant outcomes obtained from four
sources: 1) a literature review, 2) national workshops
with representatives from the 5P’s in the eight countries
in the SELFIE project, 3) eight focus groups with indi-
viduals with multi-morbidity, one in each country [29],
and 4) a review of outcomes currently being used in the
17 selected integrated care programmes. To support the
process of selecting a feasible number of outcome
measures, we clustered the outcomes into higher-level
concepts and categorised them according to the Triple
Aim, i.e., improving population health and well-being,
improving experience with care, and reducing costs or
cost-growth [30, 31]. The long-list was shortened to a
core set of outcomes, a process that was guided by the
following criteria:
 Relevance to multi-morbidity in different contexts
and population groups;
 Relevance across the 17 integrated care
programmes;
 Non-redundancy, i.e., there is little overlap between
them;
 Preference independence, i.e., the weight of one
outcome can be elicited independently from the
performance score of another outcome;
 Operationalisability, e.g., preferring original, and
widely accepted performance measures over self-
constructed scales, avoiding proxies;
 Sensitivity to short-term intervention effect, i.e., the
outcomes should be sensitive to the impact of a
programme on newly enrolled individuals within a
12 to 24 month evaluation period.
Extensive discussions within the SELFIE consortium led
to a consensus that we should focus on patient-reported
outcome measures (PROMS) and patient-reported experi-
ence measures (PREMS). These PROMS and PREMS
extend the list of structural indicators (e.g., the presence
of an individual-portal, the use of a risk-prediction algo-
rithm), process indicators (e.g., percentage of individuals
with an individual care plan), and utilisation-based proxies
of health outcomes (e.g., percentage of individuals admit-
ted to hospital for a certain complication) that pro-
grammes are frequently using for monitoring and auditing
purposes because they can easily be extracted from
existing databases. We agreed that the set of outcome
measures in our evaluations should go beyond clinical
outcomes (e.g., HbA1c in diabetes), and should focus
more broadly on well-being. Moreover, the outcomes that
were frequently mentioned by individuals with
multi-morbidity in the focus groups received high import-
ance in the selection process, which eventually led to the
core set of outcome measures shown in Table 2. This list
is termed the core set, because it pertains to outcomes to
be measured in each of the 17 SELFIE evaluations. The
fact that the core set of outcome measures is not specific
to a particular disease or programme enables the
re-usability of the importance-weights in future evalua-
tions (e.g., via the planned SELFIE online tool).
Table 2 also shows supplementary sets of outcome
measures for each of the four types of integrated care
programmes. In addition to the core set and the
programme-type specific sets of outcomes, our approach
provides researchers with flexibility to use other out-
comes, but these outcomes are not included in the
MCDA, because their relative importance is not elicited.
The outcomes in Table 2 were defined at a conceptual
level and the leaders of the MCDA-work package, pro-
vided recommendations to the other SELFIE partners
for instruments or indicators that best operationalise
these concepts. Where possible we have chosen (do-
mains) of validated instruments (See Additional file 1).
When translated versions of the instruments were un-
available, the SELFIE partners have translated them into
their own language, using an identical translation proto-
col with forward and backward translations by native
speakers. The chosen instruments were combined into a
SELFIE-questionnaire, which varied depending on the
type of programme being evaluated.
Measuring performance (step 3)
The third step in our MCDA is to measure the perform-
ance of the 17 integrated care programmes on the
selected outcome measures. Therefore, an empirical
evaluation was designed in close collaboration with the
providers and managers of each programme. Table 3
describes the participants included in the intervention
and comparator groups of the 17 programmes. More
details on the selection and inclusion of participants per
programme can be found in Additional file 2. We
adhered to the national regulations regarding medical
ethics approvals and waivers and all participants pro-
vide written informed consent before participation. As
Table 3 shows, the study designs differ across the
programmes but most of them are quasi-experimental
designs or natural experiments [32]. Like experimental
designs, the purpose is to investigate the causal rela-
tionship between the outcomes and the exposure (i.e.,
integrated care), but there is no randomisation of in-
dividuals to the intervention and comparator groups.
One of the main risks of non-randomised designs is
confounding by indication, which precludes unbiased
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causal inference. To address this, studies will make use of
(propensity score) matching or apply a regression discon-
tinuity design [33] to increase the comparability of the
comparator group to the intervention group. Furthermore,
studies apply regression adjustment and inverse probabil-
ity weighting to adjust for observed confounding [34], or
difference-in-differences analysis [35] to address unob-
served confounding. Combinations of these adjustments
for confounding are also reported in the literature [36]. In
SELFIE, most evaluations use a combination of retrospect-
ive data (retrieved from existing databases) with prospect-
ive data (collected by questionnaire) with multiple
measurement-points per individual in both the interven-
tion and comparator group.
Weighting the criteria (step 4)
In the fourth step of our MCDA, a Discrete Choice
Experiment (DCE) [37] is conducted in each country in
the SELFIE project to obtain the weights (or relative
importance) that the 5P stakeholder groups assign to the
core set of outcomes. In addition, Swing Weighting [38]
is used to elicit weights for both the programme-type
specific sets of criteria and the core set. These two
preference elicitation methods were chosen because they
force stakeholders to trade criteria off against
one-another, as opposed to merely rating a single criter-
ion [39]. Moreover, they take account of the entire range
of potential performance of integrated care programmes,
which is of particular importance for the applicability of
the weights to future MCDA evaluations. We choose to
apply two different weighting methods because DCE,
although theoretically very well-founded [40], allows
only for a limited set of criteria due to cognitive burden.
For this reason, and due to the aforementioned benefits,
swing weighting was applied for the full range of out-
come criteria.
In the DCE, choice sets with two different integrated
care programmes per choice are presented to respon-
dents and they are asked which programme they prefer.
The description of the integrated care programmes sys-
tematically differs in terms of their performance on the
core set of outcome criteria. Each outcome criterion has
three levels, generally reflecting a poor, average and good
performance on that outcome, framed in general con-
ceptual terms (See Additional file 3). All outcomes and
levels were identical between the SELFIE countries, ex-
cept for costs. The three levels of the costs were based
on country-specific estimates of the mean total health
and social care costs for people with multi-morbidity in
2017 (middle level) and increased and decreased by 20%
to obtain the poor and good performance level. The
costs were expressed in the national currency. A
D-efficient DCE design [41] with priors from the litera-
ture was created with 10 different sub-designs and 18
DCE choice-sets per sub-design; at the outset the same
DCE design was used in each questionnaire (8 countries
X 5 P stakeholder groups = 40 questionnaires). Each
respondent is asked to complete a randomly chosen
Table 2 Overview of the core set and programme-type specific outcomes in SELFIE
Outcomes for integrated care for individuals with multi-morbidity
Triple Aim Core set outcomes Programme-type specific outcomes
Population health
management
Frail elderly Palliative and
oncology
Problems in multiple
life domains
Health &
well-being
Physical functioning Activation & engagement Autonomy Mortality Self-sufficiency
Psychological
well-being
Pain and other
symptoms
Social participation/
relationships
Resilience
Enjoyment of life
Experience Person-centeredness Burden of medication Compassionate care
Continuity of care Burden of informal
caregiving
Timely access to
care
Preferred place of
death
Burden of informal
caregiving
Costs Total health- and social
care costs
Ambulatory care sensitive
hospital admissions
Living at home Justice contacts
Hospital re-admissions Falls leading to ER or
hospital admissions
ER Emergency room
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sub-design with 18 choice-sets. To reduce the overall
complexity of the choice tasks and improve response
efficiency there is level-overlap for 4 and 5 of the 8 out-
comes in one choice set. To optimise the D-efficient
DCE design, the priors were updated after the first circa
50 respondents in a stakeholder group within a particu-
lar country completed the questions (i.e., 40 updates).
An example of a DCE question is shown in Fig. 2. The
weights for each criterion-level are statistically estimated
from the likelihood that one scenario, with specific cri-
teria performance, is preferred over another. The relative
weights of best levels of each outcome criterion are used
in the calculation of the overall value score in the next
step of the MCDA.
In Swing Weighting, and specifically in the applied
Simple Multi-Attribute Rating Techniques Exploiting
Ranks (SMARTER) method [27, 42], respondents get a
description of an integrated care programme that has
the worst possible level of performance on all outcome
criteria. They are asked which criterion they would
select first to improve (i.e., to swing) from the worst to
the best level. After the chosen criterion is removed
from the entire set of criteria, they are asked which
criterion they would select second. This is continued on
until all criteria are ranked. The resulting rank order is
then turned into weights, for example, by using the rank
ordered centroid method [43]. The tables in Additional
file 4 include a description of the worst and the best
level in Swing weighting; for the outcome criteria that
are also included in the DCE the wording of these levels
is the same as for the poor and the good level in the
DCE.
An online weight-elicitation questionnaire was created
that contained a brief introduction to integrated care in
the European SELFIE project, a general explanation of
the type of questions and the perspective from which
the questions should be completed (i.e. 1 of the 5 Ps), a
detailed instruction on how to complete the DCE and
Swing Weighting questions plus examples to practice be-
fore answering the real questions, three blocks of 6 DCE
questions with some demographic questions in between,
the Swing Weighting question, and a multiple-choice
question on the level of difficulty of the questionnaire.
Definitions of the outcome criteria were provided and
Fig. 2 Example of a DCE question in the UK
Rutten-van Mölken et al. BMC Health Services Research  (2018) 18:576 Page 11 of 18
when respondents navigated over an outcome-heading in
the DCE and the Swing Weighting, the definition of that
outcome would appear. As can been seen in Fig. 2 colour
coding was used in the DCE questions, and outcomes that
had the same level in the two integrated care programmes
were presented in grey. Colour coding was also used in
the Swing Weighting where the arrows in between the
worst and best level of an outcome criterion changed from
red to green. The entire weight-elicitation questionnaire
was pilot tested in patients and elderly. To translate the
English questionnaire into the various languages, each
country used the same translation protocol including for-
ward and backward translations by native-language
speakers with an excellent level of English. The number of
Swing Weighting questions differs per country depending
on which types of programmes are being evaluated in a
particular country. The SELFIE partners translated the
weight-elicitation questionnaire into their own language,
using the same translation protocol as for the
performance-score questionnaire (described in step 3).
Each country in the SELFIE project had a target of recruit-
ing a minimum of 150 respondents from each of the 5Ps,
the sample size required to detect significant main effects
in the DCE [44]. Patients, Partners, and Professionals are
mostly recruited via professional panel organisations, or
organisations representing patients, informal carers, or
professional care providers. The strategies to recruit
Payers and Policy makers include snowballing, starting
with the identification of organisations of payers and
policy makers in a country, reaching out to them via one
or more individuals known to the SELFIE consortium,
and asking them to recruit other respondents within their
organisations.
Creating an overall value score (step 5)
In a multi-attribute value-based method of MCDA the
performance scores of the integrated and usual care
programmes (derived in step 3) and the weights of the
outcomes (derived in step 4) are combined into an
overall value for the integrated care programme and its
comparator, using a ‘weighted sum approach’ [26, 39].
This fifth step is illustrated with a hypothetical example
in Table 4, which shows the (standardised) performance
scores of two hypothetical care programmes (e.g., inte-
grated vs. usual care) on the core set of outcomes (i.e.,
criteria), the weights of these criteria from the viewpoint
of two different stakeholder groups (P1 and P2), and the
weighted aggregation. The performance scores are
standardised to remove the impact of differences in their
scales. In this example the aggregated score for ‘enjoy-
ment of life’ is calculated by multiplying the criteria
weight of stakeholder group 1 (0.30) or stakeholder
group 2 (0.15) with the standardised performance (0.80
for the integrated care programme and 0.60 for the
comparator). When these weighted performance scores
are summed across all criteria the overall value of a
programme is obtained. In this example the first stake-
holder group prefers the integrated care programme
over the comparator because it performs better on five
of the eight outcomes that are important to them. The
second stakeholder group prefers the comparator, which
performs better on social participation, physical func-
tioning, and costs; the latter two outcomes were also
considered more important by this stakeholder group
than by the first stakeholder group.
Sensitivity analyses and interpretation of results (step 6, 7)
In the sixth step, we address the uncertainty in the
MCDA results by performing a series of deterministic
sensitivity analyses. These include, for example, the ex-
clusion of certain criteria (e.g., the most dominating),
the use of weights obtained by Swing Weighting rather
than DCE, and the pooling of criteria-weights from
different stakeholder groups. Furthermore, we model the
parameter uncertainty in the performance scores and the
criteria-weights simultaneously in a probabilistic sensitiv-
ity analysis using Monte-Carlo simulation [45, 46]. In this
analysis, the joint uncertainty can be presented graphically
on an acceptability curve where the vertical axis shows the
probability of an integrated care programme to be
accepted as the preferred alternative against the compara-
tor and the horizontal axis shows different thresholds of
maximum budget available to be allocated to either
intervention or comparator, for the treatment of a given
population-size. The curve shows, for a range of available
budgets, the likelihood that the integrated care
programme is the preferred alternative (i.e., has the high-
est overall value score) while the budget-impact stays
below a budget-threshold. This new way of representing
uncertainty in MCDA may be called a Conditional
Multi-attribute Acceptability Curve (CMAC). Although
the CMAC was inspired by the cost-effectiveness accept-
ability curve (CEAC) [47], it differs because the probability
of the evaluated intervention to be cost-effective is based
on various outcomes relevant for decision-making beyond
the quality-adjusted life year (QALY), and the budget
available for the evaluated intervention is more appealing
and adaptable to decision-makers at all levels than the
monetary value of a QALY.
In the seventh and last step of the MCDA, the findings
and their robustness in the sensitivity analyses are inter-
preted and reflected upon by the researchers together
with representatives from the 5Ps. This is done in na-
tional workshops in the SELFIE partner countries and in
an international workshop. The explication of discrepan-
cies between different perspectives and the impact this
had on the relative importance of criteria and the final
results of the MCDA is expected to stimulate debate
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about the reasons underlying the differences in perspec-
tives. Ultimately, the MCDA will support the decisions
to be made regarding the reimbursement, continuation,
extension, and/or wider implementation of integrated
care programmes.
Discussion
Because resources are scarce, investing in integrated care
interventions either displaces other health care interven-
tions or requires additional financial resources from
taxes, health insurance premiums, and/or patient
co-payments. Therefore, payers and policy makers are
keen to ensure that they allocate scarce healthcare
resources only to services that have proven added value.
In the SELFIE project, we evaluate the added value of in-
tegrated care programmes using MCDA, because that
offers an evaluation framework in which a broader defin-
ition of value can be used, which is highly relevant to
the evaluation of integrated care programmes for indi-
viduals with multi-morbidity. In the SELFIE project, we
broaden the scope of outcomes to evaluate the added
value towards the Triple Aim. Moreover, because the
outcomes are weighted, an MCDA makes underlying
preferences explicit and can be done from multiple per-
spectives, i.e., in SELFIE from the perspectives of the five
stakeholder groups. Designing and updating 40 DCE’s (8
countries × 5 stakeholder groups) is quite unique in this
type of research, enabling extensive cross-country and
cross-stakeholder group comparisons of the relative
weights. We believe that the systematic and explicit
trade-off between multiple, sometimes conflicting, out-
comes in MCDA’s from different perspectives can
improve the transparency, consistency, accountability,
credibility and acceptability of policy decisions about
integrated care programmes for individuals with
multi-morbidity. However, developing a uniform MCDA
approach for application in the eight European countries
participating in the SELFIE project is associated with
many challenges. In this section, we discuss these
challenges and the solutions that we choose in SELFIE
to address them.
Common set of outcomes
Considering the variation in target groups and interven-
tions provided in the selected integrated care pro-
grammes, one of the first challenges was to define a
common set of outcomes to be measured. Given our
plan to use a more holistic, person-centred, understand-
ing of added value, we agreed on a minimum data set of
eight outcomes that mainly included patient-reported
outcomes and experience measures (PROMS and
PREMS) that cover the Triple Aim. Besides physical,
mental and social well-being from the 1984 WHO defin-
ition of health [48], the core set includes resilience and
enjoyment of life, two aspects of more positive and
active definitions of health, such as health as the ability
Table 4 Calculating overall value scores
Range
performance
score
Performance Standardised performancea Weights Weighted aggregation
Integrated
care
Comparator
worst-best Integrated
care
Comparator Integrated
care
Comparator P1 P2 P1 P2 P1 P2
Health & well-being
Physical functioning 0–100 60 70 0.65 0.76 0.100 0.250 0.065 0.163 0.076 0.190
Psychological well-being 0–100 70 50 0.81 0.58 0.150 0.100 0.122 0.081 0.087 0.058
Social participation &
relationships
0–4 3 4 0.60 0.80 0.125 0.100 0.075 0.060 0.100 0.080
Resilience 1–5 2 4 0.45 0.89 0.050 0.100 0.022 0.045 0.045 0.089
Enjoyment of life 0–4 4 3 0.80 0.60 0.300 0.150 0.240 0.120 0.180 0.090
Experience
Person-centeredness 1–4 4 3 0.80 0.60 0.100 0.050 0.080 0.040 0.060 0.030
Continuity of care 1–5 5 3 0.86 0.51 0.125 0.050 0.107 0.043 0.064 0.026
Costs
Total health and social care
costs
8500–5500 8000 6000 0.20 0.40 0.050 0.200 0.010 0.040 0.020 0.080
Overall value score 0.722 0.592 0.632 0.643
Performance: hypothetical average performance values, Weights: hypothetical weights obtained in DCE for stakeholder group 1 (P1) and 2 (P2), weighted
aggregation: aggregation of standardised performance measures using weights for each stakeholder group
aPerformance scores are standardised with the following formula: Saj ¼ xajðx2ajþ x2bj Þ1=2 , where x = performance score on the natural scale, a = integrated care,
b = comparator, j = criteria j
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to adapt presented by Huber et al. [49, 50]. Moreover, it
includes two indicators of the experienced care process,
i.e., person-centeredness and continuity of care. These
outcomes were considered highly important by the per-
sons with multi-morbidity that participated in the focus
groups.
We deliberately defined the outcomes at a conceptual
level in order to allow for the use of different instru-
ments/indicators to measure a particular outcome be-
cause some programmes have already been measuring
outcomes with certain instruments/indicators for years.
The advantage of having longitudinal data with the pre-
viously used instruments was thought to offset the dis-
advantage of not having exactly the same instruments as
included in the SELFIE-questionnaire. However, this cre-
ates the challenge of ensuring that these instruments are
conceptually similar enough to justify the application of
the same weight in the MCDA. This requires a careful
content-mapping of the instruments to the outcomes as
defined in SELFIE.
Including costs in MCDA
Related to the choice of criteria in an MCDA, is the
debate about whether or not to include costs as a criter-
ion in the MCDA analysis. Those who argue against
including costs in MCDA, argue that MCDA creates a
new composite score of benefit and that the main ques-
tion to be answered is what the opportunity costs are of
one unit of additional benefit on that composite score
[51, 52]. In other words, how much money can be spent
at maximum for one unit of this composite score? Those
who are in favour of including costs, however, argue that
each MCDA will result in a different composite score,
dependent on what criteria are included. This seems to
make it difficult to determine a threshold for a unit of
improvement [39]. They argue that by including costs in
the weight-elicitation process respondents explicitly trade
costs off against the other criteria, making their relative
contribution throughout the entire decision-making
process explicit. This is seen as being equivalent to esti-
mating willingness-to-pay values for benefits [39]. In
SELFIE, costs are included in the MCDA. We acknow-
ledge that by including costs as one of the criteria we do
not adequately address the opportunity costs of alternative
uses of resources. In most of the 17 programmes the deci-
sion context is whether to continue or roll-out piloted in-
tegrated care programmes, and the principle decision to
invest in integrated care has already been made. Hence,
the local question that remains is whether the particular
integrated care programme evaluated generates sufficient
benefits over the comparator to justify allocation of re-
sources to that particular programme. Benefits of inte-
grated care programmes are commonly expressed in
terms of the extent to which the Triple Aims are achieved.
Reducing costs is one of these aims, and hence it cannot
be seen separately from other outcome criteria.
Having said that, there are several SELFIE-partners (HU,
NL, NO, ES, UK) who, in addition to the MCDA, perform
a cost-utility analysis of the integrated care programme
versus usual care, using the EQ-5D-5L [53] to calculate
utilities and QALYs. This will allow for a comparison
between the conclusions of both types of evaluations.
Quasi-experimental study designs
Generating scientifically rigorous evidence is particularly
challenging for complex interventions that involve or-
ganisational or system-level changes, like the 17 selected
programmes [54]. In contrast to many previous evalua-
tions of integrated care programmes, in SELFIE the out-
comes are usually measured at least twice over time,
and/or data that are extracted from existing sources
cover multiple years in both the intervention and the
comparator group. For most programmes it was possible
to identify comparable control groups. However, ran-
domisation of individual patients was considered in-
appropriate because of the contamination into ‘usual
care’ that results from the interventions directed at the
professionals and other staff, entire organisations or sys-
tems in an integrated-care programme. Also, the inter-
vention might already be in a developed stage and
widespread use, raising ethical concerns about random-
isation and withholding treatment in the control group.
Even randomisation of practices, organisations or re-
gions in cluster-RCTs is often impossible, because there
might not be enough suitable organisations to be rando-
mised. Hence, most evaluations use quasi-experimental
study designs in which they need to apply appropriate
statistical techniques to increase the comparability of the
intervention and the comparator group for causal infer-
ence. One-to-one propensity score matching is often not
an option because the sample from which statistical
twins may be drawn is too small. Therefore, several
evaluations apply inverse probability weighting in which
the propensity scores are used to weigh the outcomes
estimated by repeated measurements regression equa-
tions. In contrast to one-to-one matching, no cases have
to be excluded from the comparator group in this
method. To assess the increased comparability between
the intervention and comparator group after application
of inverse probability weighting, standardised differences
in baseline individual- and disease-characteristics before
and after weighting are reported.
Evaluating population health management programmes
The study designs that were most heavily debated in the
SELFIE consortium were those to evaluate the popula-
tion health management programmes [55]. One of the
reasons was that these programmes ‘in principle’ target
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the entire population in a region, making it impossible
to form a usual care or comparator within the same re-
gion. Another reason was that these programmes may
include a mixture of very different interventions ranging
from health promotion and prevention to rehabilitation
and end-of-life support. Each of these interventions may
target a different segment of the population and there
may be a segment of the population that has never been
(directly) exposed to a particular intervention at all.
After extensive debate in the SELFIE consortium, we
were able to define an appropriate comparator group for
each of the selected population-health management
programmes. These groups either consist of the entire
population living in a different geographical region,
people being insured by a different health insurer within
the same region that does not offer integrated care,
people receiving care from different providers not
offering integrated care, or national-level population
data. However, if a population health management
programme targets people insured by particular insurers,
there may be some people from other insurers (i.e., the
comparator group) who also benefit from the new popu-
lation health management approach adopted by the pro-
viders (i.e., a spill-over effect at the professional-level).
Furthermore, unlike the other programmes that apply
prospective evaluations in which PROMS and PREMS
are repeatedly measured in the same individuals, some
population health management programmes could only
conduct cross-sectional measurements of the PROMS
and PREMS, mostly for feasibility reasons. Defining the
sample for measurement was difficult because subgroups
of the population are exposed to different interventions.
Therefore, some of the evaluations in SELFIE have added
programme-component evaluations besides the evaluation
of the entire population health management programme.
This limitation is compensated by the availability of a wide
range of routinely collected population-level health
surveillance data, claims data and structure and process
data over many years in both intervention and control
group, which allows for difference-in-differences analyses
on the entire population. The latter analyses are done in
addition to the MCDA.
Weight-elicitation
Although trading-off multiple outcomes is one of the
strengths of MCDA, the large number of outcomes for
which we had to obtain weights was a challenge. We
considered DCE’s with a partial profile design in which
each choice set includes only a subset of the attributes (i.e.,
outcomes). However, the assumption underlying partial
profiling, namely that the attributes not shown do not in-
fluence the scoring has proven to be invalid; respondents
do make assumptions about the attributes not shown [56].
In countries where two different types of integrated care
programmes are evaluated, and thus two sets of
programme-type specific outcomes are present, the re-
spondents may have to value up to 18 outcomes, which is
only feasible with Swing Weighting. In the end, our
approach results in two different sets of relative weights,
one for the core set of outcomes based on DCEs, and one
for the core set and the programme-type specific set based
on Swing Weighting. These weight sets are not directly
comparable. This calls for sensitivity analysis to investigate
how sensitive the outcomes are to these differences in
methodology.
A major strength of an MCDA is that the weights can
be obtained from multiple groups of stakeholders. We
decided to obtain weights from representatives of the
5P’s in order to inform decision makers about the extent
to which different roles lead to different opinions about
the importance of certain outcomes. This raises norma-
tive issues such as the question about whose preferences
should count most. In the end, it is up to the decision
makers to weigh the preferences of different stakeholder
groups to make a well-informed final decision.
Including five different stakeholder groups also creates
the challenge of recruiting a high number of respon-
dents. Finding the required number of 150 respondents
for the DCE among the Payers and the Policy makers
may be more difficult than recruiting 150 Patients,
Partners, and Professionals. This is especially the case in
counties with relatively few people working in health-
and/or social care policy making/advising (e.g., the
Eastern European Countries), smaller countries, or
countries where there is a single payer (i.e., a National
Health Service). Fortunately, we need less respondents
per stakeholder group for the Swing Weighting because
in that method less parameters have to be estimated.
Conclusion
In conclusion, we described a methodologically innova-
tive mixed-methods approach to perform MCDAs of 17
integrated care programmes for individuals with
multi-morbidity that we apply in 8 countries. This
approach includes qualitative research to understand the
details and decision context of the programmes and
quantitative research to measure performance on and
weights of a core set of outcomes to be used across all
programmes and four sets of programme-type specific
outcomes. This offers unique opportunities to investigate
how cross-country, cross-stakeholder and cross-method
differences in weights affect the MCDA outcomes. The
SELFIE MCDA framework can be used to improve the
transparency, consistency, accountability, credibility and
acceptability of the decision making about the implemen-
tation of integrated care for people with multi-morbidity.
The framework can also be used in future evaluation stud-
ies across Europe and beyond.
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